Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) Gross Margin (2019 - 2023)

Historic Gross Margin for Benitec Biopharma (BNTC) over the last 5 years, with Q2 2023 value amounting to 100.0%.

  • Benitec Biopharma's Gross Margin changed N/A to 100.0% in Q2 2023 from the same period last year, while for Mar 2024 it was 1471.43%, marking a year-over-year decrease of 15581900.0%. This contributed to the annual value of 100.0% for FY2023, which is 123300.0% up from last year.
  • According to the latest figures from Q2 2023, Benitec Biopharma's Gross Margin is 100.0%.
  • Benitec Biopharma's 5-year Gross Margin high stood at 100.0% for Q4 2021, and its period low was 1800.0% during Q4 2020.
  • Its 5-year average for Gross Margin is 182.68%, with a median of 21.21% in 2019.
  • Per our database at Business Quant, Benitec Biopharma's Gross Margin tumbled by -15026000bps in 2020 and then soared by 19000000bps in 2021.
  • Quarter analysis of 5 years shows Benitec Biopharma's Gross Margin stood at 297.4% in 2019, then crashed by -505bps to 1800.0% in 2020, then soared by 106bps to 100.0% in 2021, then changed by 0bps to 100.0% in 2022, then changed by 0bps to 100.0% in 2023.
  • Its Gross Margin was 100.0% in Q2 2023, compared to 100.0% in Q1 2023 and 100.0% in Q4 2022.